Microglia are highly sensitive to even small changes in the brain environment, such as invasion of non-hazardous toxicants or the presymptomatic state of diseases. However, the physiological or pathophysiological consequences of their responses remain unknown. Here, we report that cultured microglia sense low concentrations of the neurotoxicant methylmercury (MeHg low ) and provide neuroprotection against MeHg, for which astrocytes are also required. When exposed to MeHg low , microglia exocytosed ATP via p38 MAPK-and vesicular nucleotide transporter (VNUT)-dependent mechanisms. Astrocytes responded to the microglia-derived ATP via P2Y 1 receptors and released interleukin-6 (IL-6), thereby protecting neurons against MeHg low . These neuroprotective actions were also observed in organotypic hippocampal slices from wild-type mice, but not in slices prepared from VNUT knockout or P2Y 1 receptor knockout mice. These findings suggest that microglia sense and respond to even non-hazardous toxicants such as MeHg low and change their phenotype into a neuroprotective one, for which astrocytic support is required.
Microglia are highly sensitive to even small changes in the brain environment, such as invasion of non-hazardous toxicants or the presymptomatic state of diseases. However, the physiological or pathophysiological consequences of their responses remain unknown. Here, we report that cultured microglia sense low concentrations of the neurotoxicant methylmercury (MeHg low ) and provide neuroprotection against MeHg, for which astrocytes are also required. When exposed to MeHg low , microglia exocytosed ATP via p38 MAPK-and vesicular nucleotide transporter (VNUT)-dependent mechanisms. Astrocytes responded to the microglia-derived ATP via P2Y 1 receptors and released interleukin-6 (IL-6), thereby protecting neurons against MeHg low . These neuroprotective actions were also observed in organotypic hippocampal slices from wild-type mice, but not in slices prepared from VNUT knockout or P2Y 1 receptor knockout mice. These findings suggest that microglia sense and respond to even non-hazardous toxicants such as MeHg low and change their phenotype into a neuroprotective one, for which astrocytic support is required. M icroglia, the resident immune cells in the brain, continuously monitor the brain microenvironment 1, 2 and immediately respond to CNS disorders. Microglia are characterized by a very low threshold of activation, and their activation occurs within a few tens of minutes 3 . Microglial activation is a common feature of the early stage of CNS disorders 4, 5 , during which they migrate toward the lesion, phagocytose debris and mediate inflammatory reactions 6 . The P2 receptor, a receptor for extracellular nucleotides, is highly expressed in microglia and participates in these reactions 7, 8 . Extracellular ATP and other nucleotides are released or leak from injured cells under pathological conditions. For example, ATP released from apoptotic neurons contributes a 'find-me' signal 9 that activates microglial P2Y 12 receptors and induces process extension 8 . In contrast, UDP functions as an 'eat-me' signal and triggers microglial phagocytosis via P2Y 6 receptors 7 . In addition to the nucleotide-activated microglial function, microglia can release ATP [10] [11] [12] . Furthermore, microglia-derived ATP has recently been shown to activate the astrocytic P2Y 1 receptor and trigger ATP release, which in turn regulates synaptic transmission 13 . P2Y 1 receptor activation in astrocytes has been reported to induce neuroprotective effects against oxidative stress 14 , photothrombosis 15 , trauma 16 and neurotoxicants 17 . Although the physiological consequences of purinergic signal-mediated gliotransmission between microglia and astrocytes have begun to be identified, their neuroprotective roles are mostly unknown.
Methylmercury (MeHg), a well-known environmental pollutant, readily crosses the blood-brain barrier 18, 19 inducing serious neuronal damage 20 . Our previous report demonstrated that MeHg evoked ATP release from astrocytes, thereby activating their P2Y 1 receptors, which was followed by interleukin-6 (IL-6) release 17 . Additionally, the ATP release from astrocytes required a relatively high concentration of MeHg ($1 mM), whereas neuronal damage was observed at lower concentrations of MeHg (,1 mM), to which astrocytes showed no responses. Thus, other mechanisms appear to be required for neuroprotection against low concentrations of MeHg (MeHg low (50 mg/kg body weight/day) induced microglial activation but no changes in other brain cell types (i.e., neurons, astrocytes, oligodendrocytes, endothelia or pericytes) 22 . Furthermore, it has been demonstrated that human microglia are activated in the absence of significant neuronal loss in the presence of a low concentration of MeHg (i.e., ,300 ppb) 19 , indicating potential neuroprotective roles of microglia. In fact, recent reports have shown microglia-mediated neuroprotective actions including neurotrophic support during brain development 23 , neuroprotection against NMDA-induced neurotoxicity 24 and global brain ischemia 25 .
Here we report that microglia can detect MeHg low , but their neuroprotective action against MeHg low requires astrocytes. MeHg low triggered VNUT-mediated microglial ATP release, which activated P2Y 1 receptors in astrocytes thereby inducing IL-6 production and neuroprotection.
Results
Astrocytes upregulate IL-6 expression in response to MeHg high but not MeHg low . Because we previously demonstrated that interleukin-6 (IL-6) production from astrocytes was essential for neuroprotection against MeHg 17 , we first evaluated the concentration-dependency of MeHg-induced IL-6 expression in a rat primary astrocyte monoculture (Rt astrocytes). Although a high concentration of MeHg (MeHg high , $1 mM) induced a significant increase in the amount of IL-6 production from the astrocyte monoculture, a low concentration of MeHg (MeHg low ) (i.e., 0.01 or 0.1 mM for 24 h) did not increase the amount of IL-6 production from Rt astrocytes (Fig. 1a) in accordance with previous reports 17, 31 . In contrast to astrocytes, neurons were more sensitive to MeHg, and their viabilities decreased in the presence of even MeHg low (0.1 mM), at which concentration astrocytes do not induce IL-6 production 17, 31 . Because it has been reported that microglia respond to MeHg at concentrations too low to induce neuronal damage in vitro 21 , in macaques 22 and in humans 19 , we next examined IL-6 production in a microglia monoculture. The results of ELISA analysis also showed no IL-6 release from rat (Rt) microglia monocultures in the presence of any concentration of MeHg (Fig. 1b) . Serum starvation for 24 h before MeHg treatment for IL-6 measurement did not affect microglial viability (Fig. S2a) , so it is unlikely that the lack of IL-6 production from microglia is a result of cell damage owing to serum starvation. In contrast to these Rt microglial monocultures, mixed glial cultures of Rt primary astrocytes and microglia (at a ratio of 1 5 5) released IL-6 in response to MeHg low (Fig. 1c) . In accordance with IL-6 production from the glial mixed culture in response to MeHg low , conditioned media from the Rt glial mixed culture (Microglia/Astrocytes-Conditioned Medium, MACM) exhibited neuroprotective effects against MeHg low (Fig. 1d) . MACM itself did not affect neuronal viability.
Microglia release ATP in response to MeHg low . Because we previously showed that extracellular ATP is essential for IL-6 production from astrocytes 17 , we then measured ATP release from individual monocultures or mixed glial cultures. Although our previous data showed that MeHg high evoked ATP release from Rt astrocytes 17 , MeHg low (i.e., 0.01 or 0.1 mM, 3 h) induced no ATP release from the astrocyte monoculture (Fig. 2a) . In contrast, Rt microglia released ATP in response to MeHg low but not to MeHg high (1 or 3 mM, 3 h) (Fig. 2b) . At higher concentrations (i.e., $1 mM), microglia in monoculture exhibited necrotic cell death or decreased cell viability ( Fig. S2b and (Fig. 3a and 3b) . The increased frequency of astrocytic Ca 21 oscillations in the mixed glial culture was maintained for at least 3 h. In contrast to the mixed glial culture, in the Rt astrocyte monoculture, MeHg low induced no changes in the frequencies of astrocytic Ca 21 oscillations (Fig. 3b) . The increase in MeHg low -induced Ca 21 oscillations in the Rt astrocytes in the mixed glial culture was significantly suppressed by the broad P2 receptor antagonist suramin (100 mM, 30 min pretreatment) (Fig. 3b) . Based on these data, we surmised that ATP released from microglia in response to MeHg low evoked Ca 21 oscillations in astrocytes via P2 receptor activation.
Microglial ATP release is mediated by p38 activation. We then examined which intracellular signaling pathways mediate ATP release from Rt microglia. Because mitogen-activated protein kinases (MAPKs) are important for microglial activation 32 , we examined MAPK phosphorylation in a MeHg-treated Rt microglia monoculture. As shown in Figure 4b , neither ERK1/2 nor JNK showed enhanced phosphorylation (Fig. 4b) , whereas p38 MAPK phosphorylation was increased in the presence of either 0.1 or 0.5 mM MeHg (2 h treatment) (Fig. 4a) . Consistent with a previous report 33 , the Rt microglia exhibited necrotic cell death (Fig. 4c ) and the Rt mixed glial culture (Fig. 4d) , but was not observed in the absence of MeHg ( Fig. 4c and 4d ). No change in signal intensity for either phosphorylated ERK1/2 or JNK was observed in the presence of MeHg in either the monoculture or the mixed culture ( Fig. 4c and 4d ). We then examined whether activated p38 contributes to the MeHgevoked ATP release from Rt microglia. The ATP release induced by MeHg low (0.1 mM, 3 h) from the Rt microglia monoculture was significantly suppressed in the presence of the p38 inhibitor SB203580 (10 mM, 15 min pretreatment) (Fig. 4e) , indicating that p38 is essential for microglial ATP release. The MeHg low (0.1 mM, 15 min)-induced increase in Ca 21 oscillations in astrocytes in the Rt mixed glial culture was also suppressed by SB203580 (Fig. 4f) . Furthermore, MeHg low (0.1 mM, 24 h)-induced IL-6 production from the Rt mixed glial culture was also blocked by SB203580 (Fig. 4g ). These data show that p38-mediated ATP release from microglia induces P2 receptor-mediated Ca 21 oscillations in and IL-6 production by astrocytes.
MeHg
low stimulates the exocytosis of ATP from microglia via a VNUT-mediated pathway(s). MeHg has been reported to both facilitate and suppress exocytosis 17, 34, 35 . In addition, we recently reported that microglia release ATP by exocytosis via a vesicular nucleotide transporter (VNUT)-mediated pathway(s) 11 ; thus, we next investigated VNUT-mediated ATP release evoked by MeHg. Botulinum toxin A (BoNT) (5 unit/ml, 24 h pretreatment), a toxin that cleaves SNAPs 36, 37 and thereby prevents exocytosis, significantly reduced MeHg low (0.1 mM, 3 h)-evoked ATP release from the Rt microglia monoculture (Fig. 5a ). We then compared MeHg low -evoked ATP release from mouse (Ms) microglia monocultures prepared from WT and VNUT knockout mice (WT and VNU-TKO microglia, respectively). MeHg low evoked significant ATP release from WT microglia but not from a VNUTKO microglia monoculture (Fig. 5b) . VNUTKO microglia exhibited similar morphology to WT microglia ( (Fig. 5d ). In accordance with ATP release and Ca 21 oscillations, the MeHg low -evoked IL-6 production from the mixed culture was also dependent on microglial VNUT (Fig. 5e ). In the mixed culture, phase contrast images of VNUTKO microglia on WT astrocytes revealed them to be as normal as WT microglia, and the numbers of microglia on astrocytes were not different, regardless of VNUT expression in microglia (Fig. S3e) . Similarly, the morphology and numbers of Iba1 (a microglial marker)-positive cells in the mixed culture did not change in response to MeHg low (0.1 mM, 24 h) (Fig. S3f) . Taken together, these findings suggest that the lack of ATP release, Ca 21 oscillations and IL-6 release in VNUTKO microglia/WT astrocytes is unlikely to be due to MeHg-induced cell death of VNUTKO microglia.
Activation of P2Y 1 receptors in astrocytes is essential for IL-6 production from the mixed glial cultures. Microglial ATP acted on P2 receptors and then caused Ca 21 oscillations in astrocytes (Fig. 3) . In our previous study, MeHg-evoked Ca 21 signaling was mediated by P2Y 1 receptors in astrocytes 17 (Fig. 6a) . The MeHg low -evoked IL-6 production in the glial mixed culture was also dependent on P2Y 1 receptors in astrocytes (Fig. 6b) .
Both VNUT and P2Y 1 receptors are essential for an endogenous neuroprotective mechanism against MeHg low in situ. To examine glial communication-mediated neuroprotection in situ, we employed an organotypic hippocampal culture. Neuronal cell death was assessed using propidium iodide (PI) (5 mg/ml, 1 h at 37uC) incorporation, a widely used indicator of neuronal death in hippocampal slices 38 . In WT slices, MeHg low (0.1 mM, 48 h) induced no increase in PI incorporation (Fig. 7a) . MeHg high (3 mM, 48 h)-induced PI-positive cells were co-localized with the neuronal marker NeuN, but not with the astrocyte marker glial fibrillary acidic protein (GFAP) or Iba1 ( Fig. S4a-4c) . Some NeuN signals in MeHg high -treated slices were co-localized with single-stranded DNA (ssDNA), a marker of apoptosis (Fig. S4d) . When microglia or astrocytes were suppressed by minocycline or fluorocitrate (10 and 1 mM, respectively, 24 h pretreatment), MeHg low -induced PI incorporation was dramatically increased (Fig. 7b) , indicating that both microglial and astrocytic activities were required for the endogenous neuroprotective mechanism against MeHg low . We then examined the role of P2Y 1 receptor activity in this endogenous neuroprotection. The P2Y 1 receptor antagonist MRS2179 (10 mM, 24 h pretreatment) also increased PI incorporation. In addition, when extracellular IL-6 was blocked by applying an IL-6 antibody (200 pg/ml, simultaneous treatment), the PI signal was increased in the presence of MeHg low . In fact, MeHg low evoked the release of ATP and the production of IL-6 protein from WT slices (3 h and 24 h treatment for ATP and IL-6, respectively) ( Fig. 7c and 7d ). These data indicate that glial activity, P2Y 1 receptor activation and IL-6 production are essential for the endogenous neuroprotective mechanism against MeHg in WT slices. None out of minocycline, fluorocitrate, MRS2179 and the IL-6 blocking antibody affected basal PI incorporation in the absence of MeHg (data not shown). PI signals showed a characteristic spatial pattern that corresponded well to the distribution of pyramidal neurons from the CA1 region to the CA3 region ( Fig. 7a and Fig. S4e) .
To confirm the impact of VNUT-mediated ATP release on the neuroprotection observed in the in vitro study, we used hippocampal slices obtained from VNUT-KO mice (VNUTKO slices). We did not find any significant morphological abnormality or PI incorporation in the VNUTKO slices in the absence of MeHg. However, upon stimulation with MeHg low (0.1 mM, 48 h), VNUTKO slices showed increased PI incorporation (Fig. 7e and 7f) , which was restored by the exogenous application of ATP (100 mM, 30 min pretreatment) or recombinant IL-6 protein (100 pg/ml, simultaneous treatment). In addition, MeHg low failed to stimulate the release of ATP or production of IL-6 in the VNUTKO slices ( Fig. 7g and 7h) . Similar to the VNUTKO slices, the organotypic hippocampal slices from P2Y 1 R-KO mice (P2Y 1 KO slices) also showed pronounced increases in PI signals in response to MeHg low (0.1 mM, 48 h) ( Fig. 7i and 7j ). Without MeHg, PI signals were hardly detected in the P2Y 1 KO slices. Unlike the situation in VNUTKO slices, ATP did not rescue the MeHg low -induced neuronal damage in the P2Y 1 KO slices, but recombinant IL-6 protein (100 pg/ml) did (Fig. 7i and 7j) , indicating that the release of ATP or IL-6 production is essential for the neuroprotection as an signal upstream or downstream of P2Y 1 respectively, in situ. The finding that MeHg low did not increase IL-6 production in P2Y 1 KO slices also supports this idea (Fig. 7k) .
Discussion
The main findings in the present study are as follows. (i) Microglia detected MeHg low and showed activation of p38 MAPK followed by ATP release via a VNUT-dependent pathway.
(ii) Although astrocytes did not sense MeHg low , they responded to the released ATP via P2Y 1 receptors and produced IL-6, by which they protected neurons against MeHg. (iii) These microglia-originated trilateral talks among microglia, astrocytes and neurons seen in the mixed cultures were mimicked in situ, and were essential for neuroprotection against MeHg low . We have recently shown that astrocytes protect neurons against MeHg high by producing IL-6 17 .
In the present study, we focused on the effects induced by a much lower concentration of MeHg, to which astrocytes cannot respond, and investigated the role of microglia, which are highly sensitive cells, in the brain microenvironment. There are many lines of evidence suggesting that microglia are activated even in a pre-symptomatic state or in the early stages of various diseases and after insults 39, 40 . However, the physiological or pathophysiological consequences of such microglial activations in the presymptomatic state have remained largely unknown. With regard to MeHg, it is reported that although a low MeHg concentration does not cause any sign of brain damage in intoxicated human individuals, microglia are already activated 19 , suggesting a potential role of microglia in the neuroprotection against MeHg. In fact, recent reports have described the neuroprotective roles of microglia 24, 41, 42 . Here, we demonstrated that microglia function as a highly sensitive sensor of MeHg and reveal neuroprotective effects for which astrocytes are also required. MeHg low evoked ATP release but did not induce production of IL-6 in a microglia monoculture (Figs. 1b and 2b) ; by contrast, it increased neither ATP release nor IL-6 production in an astrocyte monoculture (Figs. 1a and 2a) , although MeHg high could evoke both responses 17 ( Figs 1a and 2a) . Interestingly, MeHg, even at a low concentration, could evoke both ATP release and IL-6 production in the microglia/astrocyte mixed cultures (Figs. 1c and 2c) . The simplest interpretation of these findings is that there is some form of communication between microglia and astrocytes. Eskes et al. previously showed that microglia evoke IL-6 production from astrocytes 31 ; however, the detailed molecular mechanisms underlying the communication between these cell types remain to be clarified. Our findings that pharmacological and genetic inhibition of both microglial ATP release and astrocytic P2Y 1 receptors abolished these responses seen in the mixed glial cultures, suggest that microglia can sense MeHg low , which evoked release of ATP that functions as a paracrine signal and stimulates P2Y 1 receptors in astrocytes to induce IL-6 upregulation. Although a previous report has shown that ATP induces production of IL-6 in microglia via P2X 7 receptors 43 , MeHg low did not induce IL-6 production from microglia (Fig. 1b) . This discrepancy may be explained by the fact that the amount of released ATP in the present study was too low to activate P2X 7 receptors because their activation requires a relatively high concentration of ATP (i.e., .100 mM) 43 . The findings that (1) MeHg low -evoked ATP release was significantly decreased by BoNT or in VNUTKO microglia (Figs. 5a and 5b), and (2) microglial ATP-induced Ca 21 oscillations in astrocytes were abolished in the mixed cultures of VNUTKO microglia/WT astrocytes (Fig. 5d) , indicated that the microglial ATP release in response to MeHg low should be mediated by exocytosis. Because a high concentration of ATP would be stored in exocytotic vesicles (e.g., ,100 mM in synaptic vesicles 44 ), a locally released high concentration of ATP may be able to activate P2X 7 receptors and induce IL-6 production, but in our condition this was not the case. We recently demonstrated that microglia exocytosed ATP via VNUTdependent mechanisms, and this exocytosis was dramatically increased in inflammatory conditions 11 . Thus, if microglial ATP exocytosis is enhanced in some pathological conditions such as inflammation, the released ATP might function as an autocrine signal to activate P2X 7 receptors. However, the P2X 7 receptor antagonist brilliant blue G (1 mM) did not inhibit MeHg low -induced IL-6 production (data not shown). Therefore in the present experimental condition, instead of acting as an autocrine signal, microglial ATP seemed to function as a paracrine signal to activate P2Y 1 receptors in astrocytes.
We also found that p38 MAPK is involved in microglial ATP release (Fig. 4e) . Many reports have demonstrated that p38 MAPK is a critical regulator of microglial activation 45, 46 . Although p38 MAPK activation seems to be a common pathway for microglial activation, by which various microglial responses are regulated, to date its involvement in ATP exocytosis remains unknown. However, the activation of p38 MAPK is essential for the exocytosis of matrix metalloproteinase-9 and myeloperoxidase in neutrophils 47 , and for the nucleotide-evoked exocytosis of elastase in neutrophils 48 . Thus, p38 MAPK may somehow affect the machinery of exocytosis. An initial mechanism of microglial activation by MeHg low may be mediated by oxidative stress, because MeHg has been shown to induce oxidative stress [49] [50] [51] [52] [53] and reactive oxygen species are well known to contribute to activation of both p38 MAPK [54] [55] [56] and microglia 57, 58 . Therefore, MeHg low may change the redox state of microglia, thereby causing their activation. Although the molecular mechanisms underlying the microglial sensing of MeHg low and the subsequent activation of p38 MAPK and ATP exocytosis have not been fully clarified, we clearly showed that microglia sense MeHg low and exocytose ATP via p38 MAPK-and VNUT-dependent mechanisms, which is especially important because these microglial events initiate the subsequent trilateral communication among microglia, astrocytes and neurons.
Finally, we demonstrated that the MeHg low -evoked microglia-toastrocyte communication by ATP seen in the mixed glial cultures was mimicked in situ using organotypic hippocampal slice cultures (Fig. 7) . In the slice culture experiments, we rather focused on the relationship between this form of communication and neuronal damage. Again, (1) MeHg low evoked microglial ATP exocytosis; and (2) this microglial ATP activated P2Y 1 receptors leading to the upregulation of IL-6 in the astrocytes of mixed cultures. Similarly, (1) MeHg low evoked ATP release in WT slices, which was abolished by genetic inhibition of VNUT; and (2) MeHg low evoked IL-6 production, which was abolished by genetic inhibition of either VNUT or P2Y 1 receptors (Fig. 7) . More importantly, these genetic and pharmacological inhibitions resulted in neuronal damage induced by MeHg low , which was prevented by the addition of recombinant IL-6. Regarding the mechanism of IL-6-mediated neuroprotection, we and other groups have shown that both upregulation of adenosine A 1 receptors and suppression of glutamate-mediated excitotoxicity are involved 17, 59, 60 . These results suggest that an endogenous neuroprotective mechanism(s) against brain insults is formed by the communication network among microglia, astrocytes and neurons. Microglia are especially important in this mechanism because their sensing and responses can be a trigger of a subsequent chain of responses.
As summarized in Fig. 8 , we demonstrated the following findings. Microglia, a highly sensitive microenvironmental sensor, senses MeHg low and responds via exoytosis of ATP, for which p38 MAPK and VNUT are essential. Although astrocytes do not respond to MeHg low , they receive microglial ATP through P2Y 1 receptors, produce IL-6 and thereby provide neuroprotection against MeHg low . Microglia respond to non-hazardous insults or change their phenotypes even in the presymptomatic state of diseases. Such early responses in microglia might be key events in protecting neurons, and should be studied further toward clarifying the causes of brain diseases.
Methods
Detailed methods are provided in the Supplementary information.
Animals. All animals used in this study were obtained, housed, cared for and used in accordance with the ''Guiding Principles in the Care and Use of Animals in the Field of Physiologic Sciences'' published by the Physiologic Society of Japan and with the previous approval of the Animal Care Committee of Yamanashi University (Chuo, Yamanashi, Japan). Wistar rats and C57BL/6 mice (17-day-old fetal) were obtained from Japan SLC (Shizuoka, Japan). P2Y 1 receptor knockout mice (C57BL/6 background) were developed as previously reported 26 . Vesicular nucleotide transporter knockout (VNUTKO) mice were generated by the standard gene disruption procedure. For genotyping polymerase chain reaction (PCR), the primers used were as follows: WT forward, 59-CTA TGT GTA GCC CTG GAT GG-39; WT reverse, 59-GTG TAC CCT TCG GGG AAA GT-39; VNUTKO forward (corresponding to a partial sequence inside PGK promoter that drives the Neo gene), 59-CTT GTG TTT GGG ATC CTG GT-39; and VNUTKO reverse, 59-GGG AGG ATT GGG AAG ACA AT-39. They were backcrossed onto a C57BL/6 background and used.
Cell culture. Glial monocultures were prepared as previously reported 7, 27 . Briefly, cerebral cortices dissected from newborn Wistar rats or C57BL/6 mice were digested in 0.1% trypsin-EDTA and the cells were cultured in a flask. For microglia monoculture, cells were collected by gentle shaking of the flask. For astrocyte monoculture, the flask was subjected to 24 h of continuous shaking. For the mixed glial culture, microglia were added to a confluently cultured astrocyte culture. Glial cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS), 10 units/ml penicillin, and 10 mg/ml streptomycin under conditions of 10% CO 2 at 37uC.
Neuronal culture was prepared as previously described 28 . Cerebral cortices dissected from 17-day-old fetal mice were digested in 50 units/ml papain. Neurons were maintained in neuronal culture medium (DMEM supplemented with 5% horse serum, 5% FBS, 10 units/ml penicillin, and 10 mg/ml streptomycin) under conditions of 10% CO 2 at 37uC and were treated with cytosine b-D-arabinofuranoside (ara-C, 10 mM) two days after plating. The culture medium was changed twice a week and neurons were used 14 days after plating.
Assay of cell survival. Cell survival was estimated by WST-1 assay using a cell counting kit (Dojindo, Kumamoto, Japan), which determines cell viability based on the extent of cleavage of a soluble tetrazolium salt WST-1 by mitochondrial dehydrogenases. Briefly, cells were incubated for 1 h with the WST-1 reagent at a 1510 dilution at 37uC. The absorbance of media was then measured using a microplate reader at 450 nm with 650 nm as a reference wavelength.
Organotypic slice cultures. Organotypic hippocampal slice cultures were made as previously reported 29, 30 . Briefly, hippocampi from 5-to 7-day-old mice were dissected, placed in ice-cold HBSS containing 6 mg/ml of D-(1)-glucose for 15 min, and transverse slices (300 mm) were obtained using a McIlwain tissue chopper (Mickle Laboratory Engineering Co. Ltd., Gomshall, UK). Six slices were placed on a Millicell-CM culture plate insert (PICM0RG50, Millipore, Billerica, MA, USA) and maintained in slice culture medium (50% MEM, 25% Hanks BSS, 25% heatinactivated horse serum, 2 mM L-glutamine, 6.5 g/l glucose, 100 units/ml penicillin and 100 mg/ml streptomycin) under conditions of 5% CO 2 at 37uC and used for experiments 7 days after incubation with medium change every few days. Neuronal cell death was evaluated by propidium iodide (PI) incorporation and PI fluorescence images were obtained using a Keyence BV-8000 fluorescence microscope (Tokyo, Japan) at an exposure time of 0.5 s. The PI intensity was estimated using Image J software (http://rsbweb.nih.gov/ij/). Quantitative RT-PCR. Total RNA was isolated and purified from cultured cells using RNeasy kits (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Before RNA isolation, cells were serum-starved for 24 h. Reverse transcription (RT)-PCR was performed using a one step PrimeScriptH RT-PCR Kit (Takara Bio Inc., Shiga, Japan) according to the manufacturer's protocol. The reaction mix contained 40 ng of total RNA, 200 nM primers, 100 nM TaqMan probe, Takara EX TaqH HS and PrimeScript TM RT enzyme Mix. RT-PCR amplification and real-time detection were performed using an Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Reverse transcription was performed at 42uC for 5 min followed by inactivation at 95uC for 10 s. The temperature profile consisted of 40 cycles of denaturation at 95uC for 5 s, and annealing/extension at 60uC for 34 s. The sequences of the primers and probe for rat IL-6 were as follows: TaqMan probe, 59-CAGAATTGCCATTGCACAACTCTTTTCTCA-39; forward primer, 59-CAGTGCATCATCGCTGTTCA-39; and reverse primer, 59-CATATGTTCTC-AGGGAGATCTTGGA-39. The primers and TaqMan probe for GAPDH were obtained from Rodent GAPDH Control Reagents (Applied Biosystems). Mouse IL-6 expression was estimated using the probe set (Mm0046190-m1) from Applied Biosystems.
Enzyme-linked immunosorbent assay of IL-6. MeHg-induced IL-6 production from astrocytes, microglia, astrocytes/microglia mixed culture or organotypic hippocampal slice cultures was measured using a QuantikineH rat or mouse IL-6 immunoassay kit (R&D Systems, MN, USA). The assay was performed according to the manufacturer's instructions. All standards and samples were measured using a microplate reader at a wavelength of 450 nm.
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-imaging. Changes in intracellular Ca 21 were measured using the fura 2 method with minor modifications 28 . In brief, the culture medium was replaced with balanced salt solution (BSS) of the following composition (in mM): NaCl 150, KCl 5.0, CaCl 2 1.8, MgCl 2 1.2, HEPES 25, and D-glucose 10 (pH 7.4). Cells were loaded with fura 2 by incubation with 10 mM fura 2-acetoxymethyl ester (fura 2-AM) at room temperature in BSS for 45 min. After loading, the samples were mounted on a microscope (ECLIPSE TE2000-U, Nikon, Tokyo, Japan) equipped with a 75-W xenon lamp and band-pass filters of 340 and 380 nm wavelengths for measurement of the Ca 21 -dependent signals (F340 and F380 nm). Image data were recorded using a CCD camera (ORCA-ER, Hamamatsu Photonics, Shizuoka, Japan). For evaluation, we used the F340/F380 ratio. To estimate the frequency of Ca 21 oscillations in astrocytes, we compared the numbers of Ca 21 oscillations in a single astrocyte within 5 minutes.
Immunocytochemistry and immunohistochemistry. Cells cultured in m-dish (Ibidi GmbH, Munich, Germany) or slices were serum starved for 24 h followed by MeHg low treatment (2 h) and fixed with 4% PFA for 30 min at room temperature. After permeabilization/blocking in PBS with 0.3% Triton X-100 (PBST) containing 3% goat serum for 1 h at room temperature, samples were incubated with the primary antibodies (CD11b, GFAP, Iba1, NeuN, phospho-p38, phospho-ERK1/2, phospho-JNK, and ssDNA at 151000) in Can Get Signal A (TOYOBO, Osaka, Japan) for 24 h at 4uC. Then, the cells were further incubated with Alexa dye-conjugated secondary antibodies (at 151000) for 1 h at room temperature. Fluorescence images were obtained using a laser scanning confocal microscope FV-1000 (Olympus, Tokyo, Japan). For nuclear staining, 49,6-Diamidino-2-phenylindole, dihydrochloride (DAPI) (1 mg/ml) was used.
Measurement of extracellular ATP. The extracellular ATP concentrations of MeHgtreated cells or slices were determined using an ATP bioluminescence assay kit CLS II (Roche Applied Science, Mannheim, Germany). Cells or slices were serum starved for 24 h followed by incubation for 3 h with MeHg (0.01, 0.1, 1 or 3 mM) in serum-free medium, and the supernatants were collected and immediately boiled at 95uC for 5 min. Equal volumes of luciferin/luciferase reagents and samples (100 ml each) were mixed a few times by gentle pipetting. All standards and samples were measured using a Lumat LB9501 tube luminometer (Berthold, Wildbad, Germany). The ATP concentrations were calculated from the intensities of a series of standard ATP. For glial cells, samples were collected from 24-well plates (i.e., 1 3 10 5 cells in astrocyte monocultures, 6 3 10 4 cells in microglia monocultures, or mixed cultures of 1 3 10 5 astrocytes and 2 3 10 4 microglia). For hippocampal slices, samples were collected from 12-well plates (i.e., one slice/well).
Western blotting. Cells for western blotting were serum starved for 24 h before MeHg treatment (2 h). Cell lysates were electrophoresed by 10% SDS-PAGE gels and transferred to PVDF membranes. The membranes were blocked for 1 h in Trisbuffered saline containing 0.1% Tween-20 and 5% BSA at room temperature and were incubated with primary antibodies (151000) overnight at 4uC. Membranes were then incubated with horseradish peroxidase-conjugated secondary antibodies (1520,000) for 1 h at room temperature. Protein bands were visualized by rinsing the membrane with SuperSignal West Pico Chemiluminescence Substrate (Thermo Scientific, PA, USA). Images were obtained using a LAS-4000 imaging system (Fujifilm, Tokyo, Japan). Full-length data of each blot are shown in Figure S5 .
Statistics. Data are expressed as means 6 SEM. The Student's t-test or MannWhitney U-test was used for comparisons of two groups. For multiple comparisons, one way parametric ANOVA followed by Fisher's least significant difference (LSD) test was used. Differences were considered to be significant when the P value was less than 0.05.
